Efficacy of Bimin decoction for patients with perennial allergic rhinitis: an open-label non-inferiority randomized controlled trial

被引：0
|
作者：
Jingyi Zhao
Xinyu Yan
Jianqing Gai
Jinshuai Han
Hong Zhang
Hui Luo
Shaoting Huang
Junge Wang
机构：
[1] Capital Medical University,Department of Otolaryngology, Beijing Hospital of Traditional Chinese Medicine
来源：
Trials | / 20卷
关键词：
Perennial allergic rhinitis; Traditional Chinese medicine; Randomized controlled trial; Clinical efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy and Safety of Indobufen versus Aspirin After Coronary Drug-Eluting Stent Implantation: A Randomized, Open-Label, Non-Inferiority Trial
    Wu, Hongyi
    Xu, Lili
    Zhao, Xin
    Zhang, Huanyi
    Cheng, Kang
    Wang, Xiaoyan
    Chen, Manhua
    Li, Guangping
    Huang, Jiangnan
    Zhang, Chi
    Wang, Yinman
    Ge, Lei
    Qian, Juying
    Ge, Junbo
    CIRCULATION, 2022, 146 (25) : E578 - E578
  • [22] Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial
    Belani, Pooja J.
    Kavadichanda, Chengappa G.
    Negi, Vir Singh
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (05) : 771 - 782
  • [23] Ductal Lavage versus Oral Corticosteroids in Patients with Idiopathic Granulomatous Mastitis: A Multicenter, Open-label, Randomized, Controlled, Non-inferiority Study
    Chen, Kai
    Chen, Xiaolin
    Li, Shunrong
    Zhu, Liling
    Zhang, Jian
    Hu, Tingting
    Huang, Hui
    Huang, Heng
    Chen, Lili
    Xiao, Qiaozhen
    Su, Linhong
    CANCER RESEARCH, 2024, 84 (09)
  • [24] Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial
    Pooja J. Belani
    Chengappa G. Kavadichanda
    Vir Singh Negi
    Rheumatology International, 2022, 42 : 771 - 782
  • [25] A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitis
    Barrager, E
    Veltmann, JR
    Schauss, AG
    Schiller, RN
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2002, 8 (02) : 167 - 173
  • [26] An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin plus ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial
    Randremanana, Rindra Vatosoa
    Raberahona, Mihaja
    Randria, Mamy Jean de Dieu
    Rajerison, Minoarisoa
    Andrianaivoarimanana, Voahangy
    Legrand, Agathe
    Rasoanaivo, Tsinjo Fehizoro
    Randriamparany, Ravaka
    Mayouya-Gamana, Theodora
    Mangahasimbola, Reziky
    Bourner, Josie
    Salam, Alex
    Gillesen, Annelies
    Edwards, Tansy
    Schoenhals, Matthieu
    Baril, Laurence
    Horby, Peter
    Olliaro, Piero
    TRIALS, 2020, 21 (01)
  • [27] Psychotherapy for depression in older veterans via telemedicine: a randomised, open-label, non-inferiority trial
    Egede, Leonard E.
    Acierno, Ron
    Knapp, Rebecca G.
    Lejuez, Carl
    Hernandez-Tejada, Melba
    Payne, Elizabeth H.
    Frueh, B. Christopher
    LANCET PSYCHIATRY, 2015, 2 (08): : 693 - 701
  • [28] Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial
    Li, Rong
    Zhang, Hongping
    Li, Qingshui
    Yuan, Guangwen
    Zhou, Yanjie
    Yin, Rutie
    Wang, He
    Wang, Chunyan
    Huang, Yi
    Wang, Wei
    Yan, Xiaojian
    Wu, Lingying
    Zhou, Qi
    JOURNAL OF THE NATIONAL CANCER CENTER, 2024, 4 (02): : 135 - 141
  • [29] Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
    Gu, Chengyuan
    Wang, Zengjun
    Lin, Tianxin
    Liu, Zhiyu
    Han, Weiqing
    Zhang, Xuhui
    Liang, Chao
    Liu, Hao
    Yu, Yang
    Xu, Zhenzhou
    Liu, Shuang
    Wang, Jingen
    Jia, Linghua
    Yao, Xin
    Liao, Wenfeng
    Fu, Cheng
    Tan, Zhaohui
    He, Guohua
    Zhu, Guoxi
    Fan, Rui
    Yang, Wenzeng
    Chen, Xin
    Liu, Zhizhong
    Zhong, Liqiang
    Shi, Benkang
    Ding, Degang
    Chen, Shubo
    Wei, Junli
    Yao, Xudong
    Chen, Ming
    Lu, Zhanpeng
    Xie, Qun
    Hu, Zhiquan
    Wang, Yinhuai
    Guo, Hongqian
    Fan, Tiwu
    Liang, Zhaozhao
    Chen, Peng
    Wang, Wei
    Xu, Tao
    Li, Chunsheng
    Xing, Jinchun
    Liao, Hong
    He, Dalin
    Wu, Zhibin
    Yu, Jiandi
    Feng, Zhongwen
    Yang, Mengxiang
    Dou, Qifeng
    Zeng, Quan
    CHINESE MEDICAL JOURNAL, 2023, 136 (10) : 1207 - 1215
  • [30] Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial
    Gu Chengyuan
    Wang Zengjun
    Lin Tianxin
    Liu Zhiyu
    Han Weiqing
    Zhang Xuhui
    Liang Chao
    Liu Hao
    Yu Yang
    Xu Zhenzhou
    Liu Shuang
    Wang Jingen
    Jia Linghua
    Yao Xin
    Liao Wenfeng
    Fu Cheng
    Tan Zhaohui
    He Guohua
    Zhu Guoxi
    Fan Rui
    Yang Wenzeng
    Chen Xin
    Liu Zhizhong
    Zhong Liqiang
    Shi Benkang
    Ding Degang
    Chen Shubo
    Wei Junli
    Yao Xudong
    Chen Ming
    Lu Zhanpeng
    Xie Qun
    Hu Zhiquan
    Wang Yinhuai
    Guo Hongqian
    Fan Tiwu
    Liang Zhaozhao
    Chen Peng
    Wang Wei
    Xu Tao
    Li Chunsheng
    Xing Jinchun
    Liao Hong
    He Dalin
    Wu Zhibin
    Yu Jiandi
    Feng Zhongwen
    Yang Mengxiang
    Dou Qifeng
    Zeng Quan
    中华医学杂志(英文版), 2023, 136 (10)
12345